The N-terminal domain of GPR61, an orphan G-protein-coupled receptor, is essential for its constitutive activity

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1329-1333

  Toyooka, Masaru ^a   Tujii, Takashi ^a   Takeda, Shigeki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Constitutive activity; G protein coupled receptor; GPR61

Indexed keywords

ALANINE; AMINO ACID DERIVATIVE; CD48 ANTIGEN; CD8 ANTIGEN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 61; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYBRID PROTEIN; PROTEIN GPR61; UNCLASSIFIED DRUG; VALINE; GPR61 PROTEIN, HUMAN; MUTANT PROTEIN; NERVE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN FUNCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MEMBRANE; CHEMISTRY; GENETICS; METABOLISM; POINT MUTATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELL LINE; CELL MEMBRANE; GENE EXPRESSION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MUTANT PROTEINS; NERVE TISSUE PROTEINS; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS;

EID: 65549087559     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21955     Document Type: Article

References (13)

1. Behan DP, Chalmers DT. 2001. The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool. Curr Opin Drug Discov Dev 4:548-560.
2. Bockaert J, Pin JP. 1999. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723-1729.
3. Bond RA, Ijzerman AP. 2006. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92-96.
4. Cikos S, Gregor P, Koppel J. 2001. Cloning of a novel biogenic amine receptor-like G protein-coupled receptor expressed in human brain. Biochim Biophys Acta 1521:66-72.
5. Lee DK, George SR, Cheng R, Nguyen T, Liu Y, Brown M, Lynch KR, O'Dowd BF. 2001. Identification of four novel human G protein-coupled receptors expressed in the brain. Brain Res Mol Brain Res 86:13-22.
6. Nelson CP, Challiss RA. 2007. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73:737-751.
7. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. 2002. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13:336-343.
8. Seifert R, Wenzel-Seifert K. 2002. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366:381-416.
9. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L, Leurs R. 2007. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47:53-87.
10. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR, Vaisse C. 2004. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114:1158-1164.
11. Takeda S, Yamamoto A, Okada T, Matsumura E, Nose E, Kogure K, Kojima S, Haga T. 2003. Identification of surrogate ligands for orphan G protein-coupled receptors. Life Sci 74:367-377.
12. Takeda S, Okada T, Okamura M, Haga T, Isoyama-Tanaka J, Kuwahara H, Minamino N. 2004. The receptor-Galpha fusion protein as a tool for ligand screening: a model study using a nociceptin receptor-Galphai2 fusion protein. J Biochem 135:597-604.
13. Trejo J. 2003. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther 307:437-442.